Millennium Management »

Cartesian Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $259k 25k 10.22

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Vanguard Group
683 Capital Management
Erste Asset Management GmbH
Geode Capital Management
State Street Corporation
Marshall Wace
Privium Fund Management B.V.
Jacobs Levy Equity Management
Northern Trust
Citadel Advisors
GSA Capital Partners
UBS Group
Susquehanna International

View all funds holding Cartesian Therapeutics